4.4 Review

Modulating GSH synthesis using glutamate cysteine ligase transgenic and gene-targeted mice

期刊

DRUG METABOLISM REVIEWS
卷 40, 期 3, 页码 465-477

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/03602530802186587

关键词

glutathione; glutamate-cysteine ligase; transgenic; gene-targeting; acetaminophen; liver injury; mice

资金

  1. NIEHS NIH HHS [T32ES07032, R01ES10849, U19ES11378, P42ES04696, P30ES07033] Funding Source: Medline
  2. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004696, P30ES007033, R01ES011378, R01ES010849, T32ES007032] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Glutathione (GSH) is an important antioxidant and cofactor for glutathione S-transferase conjugation. GSH synthesis is catalyzed by glutamate cysteine ligase (GCL), composed of catalytic (GCLC) and modifier (GCLM) subunits. Transgenic mice that conditionally over express GCL subunits are protected from acetaminophen induced liver injury. Gclm null mice exhibit low GSH levels and enhanced sensitivity to acetaminophen. When Gclm expression and GCL activity are restored in Gclm conditional transgenic X Gclm null mice, they become resistant to APAP-induced liver damage. These animal models are a valuable resource for investigating the role of GSH synthesis in modulating oxidative damage and drug-induced hepatotoxicity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据